spacer
spacer
Go to PDB code: 
protein links
Apoptosis PDB id
1wsx
Jmol
Contents
Protein chain
162 a.a. *
* Residue conservation analysis
PDB id:
1wsx
Name: Apoptosis
Title: Solution structure of mcl-1
Structure: Myeloid cell leukemia sequence 1. Chain: a. Fragment: residues 152-308. Synonym: myeloid cell leukemia-1. Engineered: yes
Source: Mus musculus. House mouse. Organism_taxid: 10090. Gene: mcl-1. Expressed in: escherichia coli bl21(de3). Expression_system_taxid: 469008.
NMR struc: 20 models
Authors: C.L.Day,L.Chen,S.J.Richardson,P.J.Harrison,D.C.Huang, M.G.Hinds
Key ref:
C.L.Day et al. (2005). Solution structure of prosurvival Mcl-1 and characterization of its binding by proapoptotic BH3-only ligands. J Biol Chem, 280, 4738-4744. PubMed id: 15550399 DOI: 10.1074/jbc.M411434200
Date:
12-Nov-04     Release date:   23-Nov-04    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
P97287  (MCL1_MOUSE) -  Induced myeloid leukemia cell differentiation protein Mcl-1 homolog
Seq:
Struc:
331 a.a.
162 a.a.*
Key:    PfamA domain  Secondary structure  CATH domain
* PDB and UniProt seqs differ at 4 residue positions (black crosses)

 Gene Ontology (GO) functional annotation 
  GO annot!
  Biological process     regulation of apoptosis   1 term 

 

 
DOI no: 10.1074/jbc.M411434200 J Biol Chem 280:4738-4744 (2005)
PubMed id: 15550399  
 
 
Solution structure of prosurvival Mcl-1 and characterization of its binding by proapoptotic BH3-only ligands.
C.L.Day, L.Chen, S.J.Richardson, P.J.Harrison, D.C.Huang, M.G.Hinds.
 
  ABSTRACT  
 
The B cell lymphoma-2 (Bcl-2) homologs myeloid cell leukemia-1 (Mcl-1) and A1 are prosurvival factors that selectively bind a subset of proapoptotic Bcl homology (BH) 3-only proteins. To investigate the molecular basis of the selectivity, we determined the solution structure of the C-terminal Bcl-2-like domain of Mcl-1. This domain shares features expected of a prosurvival Bcl-2 protein, having a helical fold centered on a core hydrophobic helix and a surface-exposed hydrophobic groove for binding its cognate partners. A number of residues in the binding groove differentiate Mcl-1 from its homologs, and in contrast to other Bcl-2 homologs, Mcl-1 has a binding groove in a conformation intermediate between the open structures characterized by peptide complexes and the closed state observed in unliganded structures. Mutagenesis of potential binding site residues was used to probe the contributions of groove residues to the binding properties of Mcl-1. Although mutations in Mcl-1 had little impact on binding, a single mutation in the BH3-only ligand Bad enabled it to bind both Mcl-1 and A1 while retaining its binding to Bcl-2, Bcl-xL, and Bcl-w. Elucidating the selective action of certain BH3-only ligands is required for delineating their mode of action and will aid the search for effective BH3-mimetic drugs.
 
  Selected figure(s)  
 
Figure 2.
FIG. 2. The BH3 binding activity is located in the Bcl-2 homology domain, and the C-terminal residues of this domain modulate ligand binding. A, immunoprecipitation of Mcl-1 variants from 293T cells. Equivalent 35S-labeled cell lysates from cells expressing FLAG-Mcl-1 variants and EE-Bim[EL] were immunoprecipitated using anti-FLAG M2 ( -F), anti-EE ( -E), or control anti-HA ( -H) monoclonal antibodies and fractionated on SDS-PAGE gels (left column). Western blots (middle and right columns) were performed with anti-Bim and anti-FLAG 9H1 antibodies. Mcl-1 degradation product is indicated by *. B, kinetic data for binding of BimBH3 peptide to Mcl-1 NC23 and Mcl-1 NC11. BimBH3 peptide was immobilized. C, Mcl-1 NC23 and Mcl-1 NC11 bind to the same proapoptotic proteins. The ability of the Mcl-1 proteins to bind to proapoptotic proteins was tested using GST pulldown experiments. Equivalent amounts of the GST fusion proteins were used in each experiment. Bound Mcl-1 was detected by Coomassie staining
Figure 4.
FIG. 4. Comparison of Mcl-1 and Bcl-x[L] binding grooves. A, Bcl-x[L] and Mcl-1 binding sites. Left and middle, unliganded Bcl-x[L] (PDB 1PQ0 [PDB] ) (39) and Bcl-x[L]-Bim complex with the Bim ligand removed (PDB 1PQ1 [PDB] ) (39) (respectively, ribbon residues: 90-159 and 191-196). Right, the equivalent residues (194-264 and 296-301) on Mcl-1. The orientation is the same as Fig. 3. Side chains displayed on Bcl-x[L]-Bim (middle) are those of residues that have atoms within 4 Å of a Bim atom on Bcl-x[L], and the analogous side chains are displayed on the other structures. The side chains are colored according to their proximity to a BH3-only residue (panel B). Pink represents residues close to the conserved Asp; those residues close to the conserved Leu of the BH3 domain are magenta. Cyan-, yellow-, and orange-colored residues surround the 3 hydrophobic residues at heptad positions 2d, 3d, and 4a, respectively (panel B). Other proximal residues are highlighted in blue. Bcl-x[L] Phe-97 has atoms within 4 Å of Ile-97 and Phe-101 of Bim. B, sequences of BH3 domains of mouse BH3-only proteins. The color scheme indicates key interactions consistent with those in panel A. Residues underlined in Bim and Bad are those that are helical in their Bcl-x[L] complexes (34, 39). The heptads are indicated.
 
  The above figures are reprinted by permission from the ASBMB: J Biol Chem (2005, 280, 4738-4744) copyright 2005.  
  Figures were selected by an automated process.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
20213841 D.M.Hockenbery (2010).
Targeting mitochondria for cancer therapy.
  Environ Mol Mutagen, 51, 476-489.  
20385764 D.P.Stewart, B.Koss, M.Bathina, R.M.Perciavalle, K.Bisanz, and J.T.Opferman (2010).
Ubiquitin-independent degradation of antiapoptotic MCL-1.
  Mol Cell Biol, 30, 3099-3110.  
  20838611 D.S.Dalafave, and G.Prisco (2010).
Inhibition of Antiapoptotic BCL-XL, BCL-2, and MCL-1 Proteins by Small Molecule Mimetics.
  Cancer Inform, 9, 169-177.  
  20066663 E.Fire, S.V.Gullá, R.A.Grant, and A.E.Keating (2010).
Mcl-1-Bim complexes accommodate surprising point mutations via minor structural changes.
  Protein Sci, 19, 507-519.
PDB codes: 3kj0 3kj1 3kj2
20480043 G.J.Rautureau, C.L.Day, and M.G.Hinds (2010).
Intrinsically disordered proteins in bcl-2 regulated apoptosis.
  Int J Mol Sci, 11, 1808-1824.  
20217235 L.Prochazka, L.F.Dong, K.Valis, R.Freeman, S.J.Ralph, J.Turanek, and J.Neuzil (2010).
alpha-Tocopheryl succinate causes mitochondrial permeabilization by preferential formation of Bak channels.
  Apoptosis, 15, 782-794.  
20140092 Y.Guillemin, J.Lopez, D.Gimenez, G.Fuertes, J.G.Valero, L.Blum, P.Gonzalo, J.Salgado, A.Girard-Egrot, and A.Aouacheria (2010).
Active fragments from pro- and antiapoptotic BCL-2 proteins have distinct membrane behavior reflecting their functional divergence.
  PLoS One, 5, e9066.  
19726685 E.F.Lee, P.E.Czabotar, H.Yang, B.E.Sleebs, G.Lessene, P.M.Colman, B.J.Smith, and W.D.Fairlie (2009).
Conformational changes in Bcl-2 pro-survival proteins determine their capacity to bind ligands.
  J Biol Chem, 284, 30508-30517.
PDB codes: 3io8 3io9
19021159 M.Orzáez, A.Gortat, L.Mondragón, and E.Pérez-Payá (2009).
Peptides and peptide mimics as modulators of apoptotic pathways.
  ChemMedChem, 4, 146-160.  
19229632 N.S.Chari, N.L.Pinaire, L.Thorpe, L.J.Medeiros, M.J.Routbort, and T.J.McDonnell (2009).
The p53 tumor suppressor network in cancer and the therapeutic modulation of cell death.
  Apoptosis, 14, 336-347.  
19913487 S.Oda, M.Schröder, and A.R.Khan (2009).
Structural basis for targeting of human RNA helicase DDX3 by poxvirus protein K7.
  Structure, 17, 1528-1537.
PDB code: 3jrv
18462686 C.Smits, P.E.Czabotar, M.G.Hinds, and C.L.Day (2008).
Structural plasticity underpins promiscuous binding of the prosurvival protein A1.
  Structure, 16, 818-829.
PDB codes: 2vof 2vog 2voh 2voi
18452209 D.Lama, and R.Sankararamakrishnan (2008).
Anti-apoptotic Bcl-XL protein in complex with BH3 peptides of pro-apoptotic Bak, Bad, and Bim proteins: comparative molecular dynamics simulations.
  Proteins, 73, 492-514.  
18574029 D.Trachootham, H.Zhang, W.Zhang, L.Feng, M.Du, Y.Zhou, Z.Chen, H.Pelicano, W.Plunkett, W.G.Wierda, M.J.Keating, and P.Huang (2008).
Effective elimination of fludarabine-resistant CLL cells by PEITC through a redox-mediated mechanism.
  Blood, 112, 1912-1922.  
19043450 G.Lessene, P.E.Czabotar, and P.M.Colman (2008).
BCL-2 family antagonists for cancer therapy.
  Nat Rev Drug Discov, 7, 989.  
19641510 L.P.Billen, A.Shamas-Din, and D.W.Andrews (2008).
Bid: a Bax-like BH3 protein.
  Oncogene, 27, S93-104.  
18097445 R.J.Youle, and A.Strasser (2008).
The BCL-2 protein family: opposing activities that mediate cell death.
  Nat Rev Mol Cell Biol, 9, 47-59.  
17496930 A.L.Pauleau, N.Larochette, F.Giordanetto, S.R.Scholz, D.Poncet, N.Zamzami, V.S.Goldmacher, and G.Kroemer (2007).
Structure-function analysis of the interaction between Bax and the cytomegalovirus-encoded protein vMIA.
  Oncogene, 26, 7067-7080.  
17492281 C.Aisenbrey, U.S.Sudheendra, H.Ridley, P.Bertani, A.Marquette, S.Nedelkina, J.H.Lakey, and B.Bechinger (2007).
Helix orientations in membrane-associated Bcl-X(L) determined by 15N-solid-state NMR spectroscopy.
  Eur Biophys J, 37, 71-80.  
17227711 C.Xing, L.Wang, X.Tang, and Y.Y.Sham (2007).
Development of selective inhibitors for anti-apoptotic Bcl-2 proteins from BHI-1.
  Bioorg Med Chem, 15, 2167-2176.  
17378545 G.Tang, C.Y.Yang, Z.Nikolovska-Coleska, J.Guo, S.Qiu, R.Wang, W.Gao, G.Wang, J.Stuckey, K.Krajewski, S.Jiang, P.P.Roller, and S.Wang (2007).
Pyrogallol-based molecules as potent inhibitors of the antiapoptotic Bcl-2 proteins.
  J Med Chem, 50, 1723-1726.  
17654739 J.L.Mott, and G.J.Gores (2007).
Piercing the armor of hepatobiliary cancer: Bcl-2 homology domain 3 (BH3) mimetics and cell death.
  Hepatology, 46, 906-911.  
17123957 M.Aoyagi, D.Zhai, C.Jin, A.E.Aleshin, B.Stec, J.C.Reed, and R.C.Liddington (2007).
Vaccinia virus N1L protein resembles a B cell lymphoma-2 (Bcl-2) family protein.
  Protein Sci, 16, 118-124.
PDB code: 2i39
16645638 M.G.Hinds, C.Smits, R.Fredericks-Short, J.M.Risk, M.Bailey, D.C.Huang, and C.L.Day (2007).
Bim, Bad and Bmf: intrinsically unstructured BH3-only proteins that undergo a localized conformational change upon binding to prosurvival Bcl-2 targets.
  Cell Death Differ, 14, 128-136.  
17386268 M.Kvansakul, M.F.van Delft, E.F.Lee, J.M.Gulbis, W.D.Fairlie, D.C.Huang, and P.M.Colman (2007).
A structural viral mimic of prosurvival Bcl-2: a pivotal role for sequestering proapoptotic Bax and Bak.
  Mol Cell, 25, 933-942.
PDB codes: 2jbx 2jby
18040043 M.Nguyen, R.C.Marcellus, A.Roulston, M.Watson, L.Serfass, S.R.Murthy Madiraju, D.Goulet, J.Viallet, L.Bélec, X.Billot, S.Acoca, E.Purisima, A.Wiegmans, L.Cluse, R.W.Johnstone, P.Beauparlant, and G.C.Shore (2007).
Small molecule obatoclax (GX15-070) antagonizes MCL-1 and overcomes MCL-1-mediated resistance to apoptosis.
  Proc Natl Acad Sci U S A, 104, 19512-19517.  
17389404 P.E.Czabotar, E.F.Lee, M.F.van Delft, C.L.Day, B.J.Smith, D.C.Huang, W.D.Fairlie, M.G.Hinds, and P.M.Colman (2007).
Structural insights into the degradation of Mcl-1 induced by BH3 domains.
  Proc Natl Acad Sci U S A, 104, 6217-6222.
PDB codes: 2jm6 2nl9 2nla
17452531 R.T.Uren, G.Dewson, L.Chen, S.C.Coyne, D.C.Huang, J.M.Adams, and R.M.Kluck (2007).
Mitochondrial permeabilization relies on BH3 ligands engaging multiple prosurvival Bcl-2 relatives, not Bak.
  J Cell Biol, 177, 277-287.  
17485524 S.Cooray, M.W.Bahar, N.G.Abrescia, C.E.McVey, N.W.Bartlett, R.A.Chen, D.I.Stuart, J.M.Grimes, and G.L.Smith (2007).
Functional and structural studies of the vaccinia virus virulence factor N1 reveal a Bcl-2-like anti-apoptotic protein.
  J Gen Virol, 88, 1656-1666.
PDB code: 2uxe
17209561 T.J.Malia, and G.Wagner (2007).
NMR structural investigation of the mitochondrial outer membrane protein VDAC and its interaction with antiapoptotic Bcl-xL.
  Biochemistry, 46, 514-525.  
17597151 X.Fu, J.R.Apgar, and A.E.Keating (2007).
Modeling backbone flexibility to achieve sequence diversity: the design of novel alpha-helical ligands for Bcl-xL.
  J Mol Biol, 371, 1099-1117.  
16645636 D.Zhai, C.Jin, A.C.Satterthwait, and J.C.Reed (2006).
Comparison of chemical inhibitors of antiapoptotic Bcl-2-family proteins.
  Cell Death Differ, 13, 1419-1421.  
17005564 J.Peng, C.Tan, G.J.Roberts, O.Nikolaeva, Z.Zhang, S.M.Lapolla, S.Primorac, D.W.Andrews, and J.Lin (2006).
tBid elicits a conformational alteration in membrane-bound Bcl-2 such that it inhibits Bax pore formation.
  J Biol Chem, 281, 35802-35811.  
16676002 J.Zhuang, and H.J.Brady (2006).
Emerging role of Mcl-1 in actively counteracting BH3-only proteins in apoptosis.
  Cell Death Differ, 13, 1263-1267.  
16763614 L.D.Walensky (2006).
BCL-2 in the crosshairs: tipping the balance of life and death.
  Cell Death Differ, 13, 1339-1350.  
17052454 L.D.Walensky, K.Pitter, J.Morash, K.J.Oh, S.Barbuto, J.Fisher, E.Smith, G.L.Verdine, and S.J.Korsmeyer (2006).
A stapled BID BH3 helix directly binds and activates BAX.
  Mol Cell, 24, 199-210.  
16474435 M.F.van Delft, and D.C.Huang (2006).
How the Bcl-2 family of proteins interact to regulate apoptosis.
  Cell Res, 16, 203-213.  
16763619 P.S.Schwartz, and D.M.Hockenbery (2006).
Bcl-2-related survival proteins.
  Cell Death Differ, 13, 1250-1255.  
17125150 R.L.Rich, and D.G.Myszka (2006).
Survey of the year 2005 commercial optical biosensor literature.
  J Mol Recognit, 19, 478-534.  
16201011 J.Loh, Q.Huang, A.M.Petros, D.Nettesheim, L.F.van Dyk, L.Labrada, S.H.Speck, B.Levine, E.T.Olejniczak, and H.W.Virgin (2005).
A surface groove essential for viral Bcl-2 function during chronic infection in vivo.
  PLoS Pathog, 1, e10.
PDB code: 2abo
16869785 J.M.Adams, D.C.Huang, A.Strasser, S.Willis, L.Chen, A.Wei, M.van Delft, J.I.Fletcher, H.Puthalakath, J.Kuroda, E.M.Michalak, P.N.Kelly, P.Bouillet, A.Villunger, L.O'Reilly, M.L.Bath, D.P.Smith, A.Egle, A.W.Harris, M.Hinds, P.Colman, and S.Cory (2005).
Subversion of the Bcl-2 life/death switch in cancer development and therapy.
  Cold Spring Harb Symp Quant Biol, 70, 469-477.  
16243507 S.N.Willis, and J.M.Adams (2005).
Life in the balance: how BH3-only proteins induce apoptosis.
  Curr Opin Cell Biol, 17, 617-625.  
15901672 S.N.Willis, L.Chen, G.Dewson, A.Wei, E.Naik, J.I.Fletcher, J.M.Adams, and D.C.Huang (2005).
Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins.
  Genes Dev, 19, 1294-1305.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB codes are shown on the right.